Yasuyuki Sadzuka Selected Research

1- methyl- 3- propyl- 7- N,N- dimethylpropylamide- xanthine

5/2004

Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyuki Sadzuka Research Topics

Disease

35	Neoplasms (Cancer) 07/2020 - 01/2002
9	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 03/2002
7	Carcinoma (Carcinomatosis) 06/2007 - 01/2002
6	Ascites 06/2007 - 01/2002
4	Leukemia P388 07/2020 - 09/2002
3	Melanoma (Melanoma, Malignant) 01/2019 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2003
2	Deglutition Disorders (Dysphagia) 01/2021 - 12/2020
2	Phototoxic Dermatitis (Phototoxicity) 11/2008 - 09/2006
1	Leukemia 07/2020
1	Stomatitis 01/2018
1	Experimental Melanoma 01/2018
1	Pain (Aches) 01/2018
1	Necrosis 11/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2006
1	Stomach Neoplasms (Stomach Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

14	Liposomes (Liposome)IBA 04/2018 - 01/2002
11	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2018 - 03/2002
6	Antineoplastic Agents (Antineoplastics)IBA 03/2013 - 05/2003
5	theanineIBA 09/2009 - 05/2002
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2008 - 11/2003
4	Photosensitizing Agents (Photosensitizers)IBA 11/2008 - 11/2003
4	Glutamic Acid (Glutamate)FDA Link 08/2004 - 05/2002
3	Glucose (Dextrose)FDA LinkGeneric 07/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2013 - 03/2002
3	LipidsIBA 05/2009 - 01/2002
2	Vitamin B 6IBA 07/2019 - 04/2018
2	Therapeutic UsesIBA 07/2019 - 11/2003
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2019 - 01/2018
2	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2017 - 01/2013
2	SolutionsIBA 01/2017 - 11/2008
2	Drug CarriersIBA 01/2017 - 11/2004
2	cucurbitacin EIBA 01/2010 - 04/2008
2	Connexin 43 (Connexin43)IBA 11/2008 - 06/2005
2	ConnexinsIBA 09/2008 - 06/2005
2	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 09/2006 - 11/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2005 - 11/2002
2	Peptides (Polypeptides)IBA 11/2004 - 01/2004
2	NucleosidesIBA 05/2004 - 01/2004
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2003 - 12/2002
2	Protein Isoforms (Isoforms)IBA 12/2002 - 05/2002
1	SolventsIBA 01/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 07/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 07/2020
1	Oxygen (Dioxygen)IBA 07/2020
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 07/2019
1	PyridoxalIBA 07/2019
1	PyridoxamineIBA 07/2019
1	LigandsIBA 04/2018
1	Laminin ReceptorsIBA 04/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2018
1	CitrullineIBA 01/2014
1	Volatile Oils (Essential Oils)IBA 03/2013
1	linaloolIBA 03/2013
1	cif nucleoside transporterIBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA 01/2013
1	CurcuminIBA 08/2012
1	Multidrug Resistance-Associated ProteinsIBA 01/2010
1	verlukastIBA 01/2010
1	Taurine FDA Link 09/2009
1	cyclopropapyrroloindoleIBA 11/2008
1	Singlet OxygenIBA 11/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2008
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 09/2008
1	Capsaicin (Zostrix)FDA Link 04/2008
1	ferulic acid (sodium ferulate)IBA 04/2008
1	gingerolIBA 04/2008
1	DipeptidesIBA 06/2007
1	AnserineIBA 06/2007
1	Polymethyl Methacrylate (Sol)IBA 09/2006
1	Anticarcinogenic AgentsIBA 06/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2005
1	polyethylene glycol 2000IBA 01/2005
1	alanyl-prolyl-arginyl-prolyl-glycineIBA 11/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2004
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 11/2004
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2004
1	1- methyl- 3- propyl- 7- N,N- dimethylpropylamide- xanthineIBA 05/2004
1	leucylarginineIBA 01/2004
1	dpp-cndacIBA 01/2004
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2004
1	leucylprolineIBA 01/2004
1	Peptide LibraryIBA 01/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2004
1	glycylproline (Gly-Pro)IBA 01/2004
1	2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA 01/2004
1	Glutathione (Reduced Glutathione)IBA 12/2003
1	glutathione transporterIBA 12/2003
1	serine O-sulfateIBA 12/2002
1	dihydrokainic acidIBA 12/2002
1	Cisplatin (Platino)FDA LinkGeneric 11/2002
1	XanthineIBA 09/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2018 - 12/2003
6	Therapeutics 07/2020 - 01/2004
4	Photochemotherapy (Photodynamic Therapy) 11/2008 - 11/2003
3	Lasers (Laser) 11/2008 - 09/2006
1	Oral Administration 12/2020
1	Cryotherapy (Therapy, Cold) 01/2018
1	Aftercare (After-Treatment) 01/2017